IRCCS Istituto Giannina Gaslini — Sponsor Intelligence | 8 EU Trials

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

4 Recruiting

2 Completed trials

7 Countries active

27 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase I (Other)

Phase III: 2 Phase II: 2 Phase IV: 3 Phase I (Other): 1

Oversight events:

1 corrective measure across 1 trial

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Cystic fibrosis 1 Neutropenia 1 Neuroblastoma 1 Juvenile idiopathic arthritis 1 Graft infection 1

Top IMPs

ABATACEPT 1 ADALIMUMAB 1 ALLOGENEIC PERIPHERAL BLOOD-DERIVED HAEMATOPOIETIC STEM CELLS, TCR ALPHA/BETA+ CD19+ DEPLETED 1 ALLOGENEIC PERIPHERAL BLOOD-DERIVED NK CELLS CD3- CD56+ 1 ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT 1 BARICITINIB 1 CANAKINUMAB 1 CLONIDINE HYDROCHLORIDE 1 DINUTUXIMAB BETA 1 ETANERCEPT 1 FLUDARABINE PHOSPHATE 1 GOLIMUMAB 1

All trials

8 total

A low-intervention prospective-retrospective study to evaluate the pharmacokinetics of elexacaftor/tezacaftor/ivacaftor combination in a Cys… Pending

2024-518785-28-00 Phase IV 1 country IVACAFTOR; TEZACAFTOR, ELEXACAFTOR, IVACAFTOR
Use of pegfilgrastim in severe chronic neutropenia Pending

2024-519009-36-01 Phase II 1 country PEGFILGRASTIM
Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized cli… Recruiting

2024-514732-24-00 Phase IV 7 countries ABATACEPT; ADALIMUMAB; BARICITINIB; ETANERCEPT; GOLIMUMAB; METHOTREXATE; SECUKIN…
Intrathecal MoRphine versus TAP Block for AnalGesic management in Elective caesarean section performed under neuraxial anesthesia. A monocen… Recruiting

2024-513150-29-00 Phase IV 1 country CLONIDINE HYDROCHLORIDE; MORPHINE HYDROCHLORIDE TRIHYDRATE; ROPIVACAINE HYDROCHL…
(MOTOR Study) Neuromuscular MOniTOring in pediatric anesthesia. Randomized clinical study Recruiting

2024-517057-27-00 Phase III 1 country ROCURONIUM BROMIDE; SUGAMMADEX
TCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neurob… Recruiting

2024-519089-32-02 Phase II 1 country ALLOGENEIC PERIPHERAL BLOOD-DERIVED HAEMATOPOIETIC STEM CELLS, TCR ALPHA/BETA+ C…
Linfociti T virus-specifici per infezioni virali resistenti alla terapia farmacologica dopo trapianto allogenico di cellule staminali emopoi… Ended

2024-518925-14-02 Phase I (Other) 1 country PTC:VS-TC
A double-blind, placebo-controlled, randomized withdrawal study of canakinumab in pyogenic sterile arthritis pyoderma gangrenosum and acne (… Ended

2024-517155-13-00 Phase III 1 country CANAKINUMAB

Showing 1–8 of 8 trials

← All sponsors A–Z